AFib is a growing crisis in Electrophysiology (EP). This condition affects more than 37 million people.1 We create bold solutions to challenge AFib. This is a suite technology that boldly redefines the EP lab. Clinical support that elevates your practice to meet today’s challenges. It is a partnership to drive impact and grow the EP community.
FROM 37 MILLION TODAY, TO MORE THAN 60 MILLION BY 20501,2
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?